Multiple Manufacturers



Multiple Manufacturers

Remodulin HCPCS:


HCPCS Code Descriptor:

Injection, treprostinil, 1 mg


J Code

Remodulin NDCs:

66302-0110-01, 00703-0696-01, 42023-0209-01, 43598-0648-11, 00781-3430-80, 66302-0105-01, 42023-0208-01, 00703-0686-01, 00781-3427-80, 43598-0647-11, 66302-0102-01, 00703-0676-01, 42023-0207-01, 00781-3425-80, 43598-0646-11, 66302-0101-01, 42023-0206-01, 00703-0666-01, 00781-3420-80, 43598-0649-11

Primary Type:


Generic/Specialty Status:


Route of Administration:


Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

42023-0209-01, 42023-0208-01, 42023-0207-01, 42023-0206-01

About Remodulin:

REMODULIN is a Cardiology drug manufactured by United Therapeutics and administered via the Injection route of administration. The J Code: J3285 is aligned to the drug REMODULIN.

Remodulin belongs to the group of medications known as vasodilators. Remodulin works by dilating the blood vessels in the lungs and helps to mitigate the symptoms of high blood pressure. Remodulin is administered via subcutaneous infusion or an intravenous infusion. Remodulin is a generic drug that is manufactured by Sicor Pharmaceuticals, Sandoz, and Par Pharmaceutical Incorporated. Patient assistance programs for this medication can be found through United Therapeutics.


J3285 Added Date:

January 1, 2006

J3285 Effective Date:

January 1, 2006

J3285 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Remodulin billing and coding information.
Remodulin patient assistance information can be found through Archways Patient Support at the URL:
REMODULIN prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for REMODULIN. Please check back in a few weeks.